Chile Sessions: Contest for Interventionists in Training

Sponsored by Abbott Vascular LATAM

XXXI SOLACI Sessions – Southern Cone Region 10°

November 30th – December 1st, 2016. Puerto Varas – Chile

Case Submission: “Fostering Hemodynamics among Young Cardiologists”.

jornadas_chileIt is with great pleasure that we hereby invite all young Latin American cardiologists specializing in hemodynamics to submit relevant clinical cases to the next SOLACI Sessions, Puerto Varas-Chile 2016, to be held on November 30th and December 1st, 2016.

Participants will be competing for the “best case” prize, which consists of complete coverage to attend to a SOLACI Session 2017,  including air fare, accommodation and registration. Winner will have the chance to choose amongst three SOLACI Sessions 2017 destinations: Bogotá – Colombia, Santa Cruz de la Sierra – Bolivia or Panamá City – Panamá.

Submitted cases must be of educational value and must pertain to the field of interventional cardiology.

All cases will be initially evaluated by the appointed committee and shortlisted to the best 8, which shall be presented orally during our sessions. During these presentations, a second complementary evaluation will decide on the winner.

Submission deadline is Monday October 31, 2016.

Submission status will be communicated on Wednesday November 7, 2016 through SOLACI web page.

 Submission Criteria and Specifications:

 

  • Case submission is meant for young Latin American interventional cardiologists and topics include: adult peripheral vascular and structural heart interventional cardiology.

 

  • In each case only one interventionist can sign. Being a fellow cardiologist or interventionist is not required.

 

  • Attach a letter of recommendation from the Chief of the Hemodynamic Service you belong to.

 

  • Send a Word file with your case description, no longer than 300 words, font size 11.

 

  • Send a complementary Power Point file with your case presentation. Even though you may use videos for your oral presentation during our sessions (up to 5), this initial file may only include up to 5 pictures only.

 

  • One cardiologist may present more than one case. If such were the case, they should be sent separately.

 

  • Cases shall be submitted via this .

 

Dr. Jorge Mayol

       SOLACI Session Director

Dr. Mario Araya

       SOLACI Sessions Vice Director

Drs. Mario Araya, Manuel Méndez and Jorge Assef

Organizing Committee of SOLACI Sessions Chile 2016

Dr. Gastón Dussaillant

President of the Scientific Committee of SOLACI Sessions Chile 2016

Dr. Pedro Trujillo

       Coordinator of the Contest for Interventionists in Training – SOLACI Sessions

 

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...